APOE and early-onset autosomal dominant Alzheimer disease: ApoE ɛ2, ɛ3, and ɛ4 alleles strongly alter, in a dose-dependent manner, the likelihood of manifesting Alzheimer's disease and cerebral amyloid angiopathy (Verghese et al. 2011).